Zepbound 7.5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DR26FM4L7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $82,692
Award facts
- Contract value 100% obligated
- $82,692.17 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $82,692.17 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 ml pen injectors on November 20, 2025, with completion scheduled for November 21, 2025. This firm fixed price delivery order was competitively awarded without set-aside designation and will be fulfilled from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Zepbound is a pharmaceutical product used in diabetes and weight management treatment, consistent with AmerisourceBergen's extensive portfolio of brand-name and generic medications supplied to federal healthcare systems.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including support for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The contract demonstrates AmerisourceBergen's established capability as a critical pharmaceutical vendor within the federal medical supply chain through competitively awarded contracts involving firm fixed pricing across a broad spectrum of therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FM4L7?
SPE2DR26FM4L7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 20, 2025.
How much is contract SPE2DR26FM4L7 worth?
The government has obligated $82,692 on SPE2DR26FM4L7.
Is contract SPE2DR26FM4L7 an order under another contract?
Yes. SPE2DR26FM4L7 is a delivery order under SPE2DR25D2211, an indefinite delivery contract.
Was contract SPE2DR26FM4L7 competed?
The extent of competition for SPE2DR26FM4L7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award